This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Results for heparin

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

With regard to heparin treatment:

  • the heparin group suffered non-significantly fewer deaths within 14 days:
    • 9.0% heparin vs. 9.3% no heparin
    • corresponding to 3 fewer deaths per 1000 patients

  • the percentage dead or dependent at 6 months was identical in both groups, at 62.9%

  • heparin treatment significantly reduced recurrent ischaemic events:
    • 2.9% vs 3.8%

  • heparin treatment resulted in more haemorrhagic strokes:
    • 1.2% vs. 0.4%

  • 125000 IU bd resulted in significantly more transfused or fatal extracranial bleeds, more haemorrhagic strokes, and more deaths or non-fatal strokes within 14 days:
    • 12.6% vs 10.8%

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.